Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
Date:10/12/2010

X to be used in multiple indications; and products in development for Frozen Shoulder syndrome, overactive bladder, pain, hormone replacement and urologic disease. All statements other than statements of historical facts contained in this release, including but not limited to, statements regarding future expectations, plans and prospects for the Company, statements regarding forward-looking financial information and other statements containing the words "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and similar expressions, as they relate to the Company, constitute forward-looking statements. Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, the performance of third-party service providers, decisions by regulatory authorities regarding whether or when to proceed to the next phase of clinical trials, general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2009 under the heading "Risk Factors," and in Auxilium's Quarterly Report on Form 10-Q for the period ended June 30, 2010, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actual results to differ from those contained in forward-looking statements. Given these risks and
'/>"/>
SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
2. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
3. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
6. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
7. MAP Pharmaceuticals, Inc. Announces Pricing of Underwritten Registered Offering of Common Stock
8. Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
9. Access Pharmaceuticals, Inc. Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
10. Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis
11. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  The packaging industry plays ... not only provides containment and drug safety but ... delivery. As patent loss delivers more generics into ... rise, in turn encouraging low-cost innovation in emerging ... to drive the pharmaceutical packaging industry towards low-cost, ...
(Date:3/3/2015)... DUBLIN , March 3, 2015 Actavis ... it has priced an offering of $21 billion aggregate ... in a registered public offering to be issued by ... by certain of its other subsidiaries (the "Notes"), as ... to PublicFloating Rate Senior Notes* , $500,000,000 ...
(Date:3/3/2015)... AUSTIN, Texas , March 3, 2015  Vermillion, Inc. ... on gynecologic disease, today announced management will present at the ... at the Ritz-Carlton in Dana Point, California ... President and CEO of Vermillion, Valerie Palmieri , will ... She will be joined by Eric Schoen , the ...
Breaking Medicine Technology:Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" ... specialty pharmaceutical company focusing on the development, manufacturing, marketing ... today announced its financial results for the quarter and ... Financial Results for the Quarter ...
... Md., March 25, 2011 The U.S. Food and Drug ... late-stage (metastatic) melanoma, the most dangerous type of skin ... Melanoma is the leading cause of death ... melanoma were diagnosed in the United States during 2010 ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 2Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 3Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 4Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 5Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 6Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 7Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 8Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 9Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 10Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 11Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 12Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 13Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 14FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 2FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 3
(Date:3/3/2015)... (PRWEB) March 04, 2015 As payers ... value-based payment contracts within the next few years, they ... the significant chunk of health care spending they control ... Inc.’s ACO Business News (ABN) tracks some of ... of a commercial accountable care organization (ACO)-type model. , ...
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, ... States District Court for the Northern District of Ohio ... as insurance companies Balboa, QBE, and Newport Management. (See ... 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, says ... her to buy too much insurance at rates that ...
(Date:3/3/2015)... March 03, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... NOVAtime SaaS Workforce Management / Time and ... attendance processes. , Since 2004, Innovative Services’ ... disabilities with the best quality of life. The ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Risperdal ... to market the atypical antipsychotic medication continue to ... to court documents, the South Carolina Supreme Court ... Johnson & Johnson’s Janssen Pharmaceuticals unit had deceptively ... However, while the Court’s February 25th decision characterized ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... New research shows bone marrow stem cells may help ... reporting at the American Heart //Association’s Scientific Sessions 2003 ... breakthrough trial that took place in 2001. Results from ... made from his own bone marrow had improved heart ...
... predict a person's risk of developing heart disease in ... finds childhood levels of low-density lipoprotein, or LDL, and ... wall thickness in young adults. The carotid artery is ... transports blood from the heart to the brain. Thickening ...
... are obese are more likely to have behavior problems ... University of Michigan studied more than 750 children between ... took part in the National Longitudinal Survey //of Youth ... health, education, demographic, and socioeconomic status. Children were classified ...
... in nearly half of the cases, Some pre-term births are ... //bleeding or stretching of the uterus. But in the rest, ... explain part of the problem. ,Premature birth -- when ... is a major public health concern because underdeveloped babies are ...
... the virus that killed 774 people remains unknown. Scientists believe people ... another source.// ,"You might want to quarantine the pets ... on emerging diseases at the University of Texas Medical Branch in ... cat to cat, it doesn't take much of a leap of ...
... creating a whole new experience for patients in dentist ... more smiles on their patients' faces.// ,Laser procedures ... removal, less bleeding and less discomfort for patients. There ... diagnose cavities, while others remove gum and tooth structure ...
Cached Medicine News:Health News:Elevated LDL levels in Childhood could be Predictors of Heart Disease 2Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2Health News:Some pets found to be SARS carriers 2
Scoville-Greenwood bayonet forceps...
Angled 60 degree blades 5.5 mm....
... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
Medicine Products: